Oral & Maxillofacial Surgery: Page 10

Hansamed to buy Antibe's Citagenix for $6.5M

By DrBicuspid.com staff writers

Canadian pharmaceutical and medical device distributor Hansamed signed a deal to buy Antibe Therapeutics' subsidiary Citagenix for $6.5 million.

May 1, 2022

AAIDF opens grant applications

By DrBicuspid.com staff writers

The American Academy of Implant Dentistry Foundation (AAIDF) recently opened applications for its 2022 large research grants, which support dental implant research projects.

April 28, 2022

Mich. oral surgeon must pay $2.75M in malpractice case

By Melissa Busch

An oral surgeon in Michigan must pay $2.75 million in a medical malpractice case for reportedly injuring a 32-year-old's carotid and lingual arteries, leaving him with mouth numbness and trouble chewing, according to a press release issued by the patient's attorney.

April 25, 2022

Surgery for drooling leads to life-threatening outcome

By Melissa Busch

A 6-year-old boy with autism experienced life-threatening throat swelling and airway compromise following a submandibular gland ligation procedure to control his drooling, according to a short communication published April 18 in Advances in Oral and Maxillofacial Surgery.

April 19, 2022

Is it time to change antibiotic prophylaxis guidelines?

By Melissa Busch

A group of dentists and physicians called for the ADA and the American Association of Orthopaedic Surgeons to reevaluate the use of antibiotic prophylaxis for patients with prosthetic joints in a commentary published in the Journal of the American Dental Association.

April 17, 2022

Dental Dose: The new AHA infective endocarditis guidelines

By Theresa Pablos

Last spring, the American Heart Association (AHA) changed its guidance regarding the use of antibiotic agents to help prevent infective endocarditis following dental procedures. Tom Viola shares what you need to know on the latest episode of Dental Dose.

April 14, 2022

What you need to know about the U.S. No Surprises Act

By Melissa Busch

The U.S. No Surprises Act, which took effect in January, aims to protect patients from unexpected hospital bills. It also directly affects oral and maxillofacial surgery, according to a perspective published April 9 in the Journal of Oral and Maxillofacial Surgery.

April 12, 2022

Can antihypertensive drugs prevent jaw bone loss?

By Melissa Busch

Cone-beam computed tomography scans show antihypertensive drugs may positively affect the thickness of the jawbone cortex, possibly preventing bone loss. The study was published April 4 in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.

April 10, 2022

Week in Review: Pulling healthy teeth | Increased oral cancer risk? | Happy dental hygienists week

By Theresa Pablos

April 8, 2022

Root canal sealer found in woman with nerve injury

By Melissa Busch

A 27-year-old woman lost sensation in her chin and lip following root canal treatment on her mandibular molar. Months later, specialists confirmed that extrusion of the root canal sealer caused the patient's permanent anesthesia, according to a case report published April 1 in Oral Surgery.

April 7, 2022

Tramadol-dexketoprofen combo effective for 3rd-molar extraction

By Hannah Welk

A combination of the opioid class drug tramadol and nonsteroidal anti-inflammatory drug (NSAID) dexketoprofen proved more effective than ibuprofen alone for managing pain after third-molar extraction, according to a report published in the Journal of Evidence Based Dental Practice.

March 28, 2022

Week in Review: Girl diagnosed with rare, life-threatening lesion | Sugar substitutes linked to cancer | Dentistry responds to the crisis in Ukraine

By Theresa Pablos

March 25, 2022

Previous Page

Page 10 of 119

Next Page